课题基金 / 基金详情

NON-MYELOBLATIVE HAPLOIDENTICAL HSCT WITH NK CELL INFUSIONS IN HIGH RISK MYELOID

NON-MYELOBLATIVE HAPLOIDENTICAL HSCT WITH NK CELL INFUSIONS IN HIGH RISK MYELOID
高风险骨髓中 NK 细胞输注的非成髓性单倍体 HSCT
批准号:
7375910
负责人:
DANIEL J WEISDORF
金额:
$0.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

DANIEL J WEISDORF的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。所列机构为中心机构,不一定是研究者机构。本研究旨在评估自然杀伤(NK)细胞输注对接受降低强度移植前方案和来自单倍体相合相关供体的干细胞移植的患者的影响。我们的假设是,将NK细胞添加到该标准方案中将降低GVHD的发生率,而不影响植入或导致额外的+100天死亡率。此外,NK细胞输注可能会限制移植后癌症复发的风险。我们还在测试NK细胞输注的安全性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is being done to evaluate the effects of an infusion of natural killer (NK) celss given to patients receiving a reduced intensity pre-transplant regimen and stem cell trnsplant from a haploidentical related donor. Our hypothesis is that the addition of NK cells to this standard regimen will reduce the incidence of GVHD without compromising engraftment or leading to excess day +100 mortality. Additionally, the NK cell infusion may limit the risks of cancer relapse after transplant. We are also testing the safety of the NK cell infusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MT2003-23:NON-MYELOBLATIVE HAPLOIDENTICAL HSCT WITH NK CELL INFUSIONS IN HIGH RI
  • 批准号:
    7605991
  • 项目类别:
  • 资助金额:
    $0.35万
  • 财政年份:
    2006
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
Clinical Transplantation Exploiting NK Cell Activity
  • 批准号:
    8533762
  • 项目类别:
  • 资助金额:
    $46.12万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
Off-The-Shelf Dual Targeted NK Cells For NHL
  • 批准号:
    10390387
  • 项目类别:
  • 资助金额:
    $37.17万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
Clinical Transplantation Exploiting NK Cell Activity
  • 批准号:
    8321400
  • 项目类别:
  • 资助金额:
    $42.14万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
海外基金